Avalo Therapeutics, Inc. (AVTX) vs Mesa Laboratories, Inc. (MLAB)
A side-by-side comparison of Avalo Therapeutics, Inc. and Mesa Laboratories, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVTX
Avalo Therapeutics, Inc.
$13.86HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
MLAB
Mesa Laboratories, Inc.
$137.40HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
Total return — AVTX vs MLAB
growth of $100 · dividends reinvested · last 10yAVTX -99.9% (-48.7%/yr)MLAB +27.4% (+2.4%/yr)MLAB compounded faster over this window
Log scale — wide-divergence pair
AVTX MLAB
AVTX vs MLAB: by the numbers
- •MLAB is the larger company ($769M vs $728M market cap).
- •MLAB is profitable (1.92% net margin) while AVTX runs a net loss (-170055.93%).
- •MLAB grew revenue faster over the past five years (12.45% vs -60.88% CAGR).
- •MLAB pays a dividend (0.45% yield), while AVTX has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | AVTX | MLAB |
|---|---|---|
| P/E ratio | N/A | 163.57 |
| PEG ratio | N/A | 12.04 |
| P/S ratio | 12344.01 | 3.08 |
| P/B ratio | 1.62 | 4.07 |
| EV / EBITDA | N/A | 18.48 |
| FCF yield | N/A | 6.88% |
Profitability
| Metric | AVTX | MLAB |
|---|---|---|
| Gross margin | 100.00% | 65.99% |
| Operating margin | -123601.69% | 9.00% |
| Net margin | -170055.93% | 1.92% |
| ROE | -22.36% | 2.54% |
| ROIC | -19.45% | 3.29% |
Dividends
| Metric | AVTX | MLAB |
|---|---|---|
| Dividend yield | N/A | 0.45% |
| Payout ratio | N/A | 76.19% |
Growth (annualized)
| Metric | AVTX | MLAB |
|---|---|---|
| Revenue CAGR (5Y) | -60.88% | 12.45% |
| EPS CAGR (5Y) | N/A | 13.08% |
| FCF CAGR (5Y) | N/A | 4.63% |
| Total return CAGR (5Y) | -70.04% | -13.52% |
Frequently asked
- Which has grown faster, AVTX or MLAB?
- Over the past five years, MLAB grew revenue faster — AVTX at a -60.88% CAGR versus MLAB at 12.45%.
- Does AVTX or MLAB pay a bigger dividend?
- MLAB pays a dividend (0.45% yield), while AVTX has no payments in the available dividend history.
- Is AVTX or MLAB more profitable?
- MLAB runs the higher net margin — AVTX at -170055.93% versus MLAB at 1.92%.
- How have AVTX and MLAB total returns compared?
- Over the past 10 years, AVTX delivered -48.70% and MLAB delivered 2.29% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Mesa Laboratories P/E ratioMesa Laboratories dividend yieldAvalo Therapeutics ROEMesa Laboratories ROEAvalo Therapeutics operating marginMesa Laboratories operating marginAvalo Therapeutics revenue growthMesa Laboratories revenue growthAvalo Therapeutics free cash flowMesa Laboratories free cash flow
Avalo Therapeutics & Mesa Laboratories appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.